ArticleAdvances in therapy2026

Association Between Efficacy and Pharmacokinetics of DMB-3115 and its Originator Ustekinumab in Patients with Chronic Plaque Psoriasis: An Exposure-Response Analysis.

Hironori Konishi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.